Reaction Details Report a problem with these data
Target
Histone acetyltransferase KAT2B [719-832]
Ligand
BDBM311406
Substrate
n/a
Meas. Tech.
PCAF AlphaLisa Binding Assay
IC50
410±n/a nM
Citation
 Albrecht, BK; Cote, A; Crawford, T; Duplessis, M; Good, AC; LeBlanc, Y; Magnuson, S; Nasveschuk, CG; Pastor, R; Romero, AF; Taylor, AM Therapeutic compounds and uses thereof US Patent  US10155764 Publication Date 12/18/2018 
Target
Name:
Histone acetyltransferase KAT2B [719-832]
Synonyms:
KAT2B | KAT2B_HUMAN | PCAF | PCAF (aa 719-832)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
13623.13
Organism:
Homo sapiens (Human)
Description:
Q92831[719-832]
Residue:
114
Sequence:
SKEPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNRYYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK
  
Inhibitor
Name:
BDBM311406
Synonyms:
US10155764, Example 3
Type:
Small organic molecule
Emp. Form.:
C14H20N4O2
Mol. Mass.:
276.3342
SMILES:
COc1ccc2c(c1)c(NCCN(C)C)nn(C)c2=O
Structure:
Search PDB for entries with ligand similarity: